Field notes — week of Jan 19, 2026

Most conversations this week circled health and longevity, strategy and commercialisation and digital twins. The recurring problem: biological data is abundant, but explainable, personalised action is scarce. The implication is slow, expensive decisions made on stale information. The need is interoperable structure over raw data — and that's where we operate.